The Paradigm (ASX: PAR) share price is up 2.8% after the company reported a loss in its first-half FY21 earnings. Here’s a closer look.
The post Why is the Paradigm (ASX:PAR) share price climbing today? appeared first on The Motley Fool Australia. –
The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price gained ground today and is presently trading at $2.55 a share, a 2.82% bounce.
The share price increase comes after Paradigm released its 1HY21 financial results.
Here’s the rundown of what we found out.
Paradigm share price rises after company reports loss
Paradigm reported a net profit after taxes (NPAT) loss of $20.7 million for 1HY21. This compares to the $5.1 million loss reported for 1HY20.
The company advised that the increased NPAT loss was a product of the significant progress made with its osteoarthrosis (OA) and mucopolysaccharidosis (MPS) clinical programs.
Specifically, the company incurred the costs and expenses reflected in the NPAT loss in order to launch phase II and phase III trials for the treatment of MPS. Paradigm also allocated additional expenses to convene meetings pertaining to OA with the United States Food and Drug Administration and European Medicines Agency.
As of 31 December 2020, Paradigm posted $95.3 million worth of assets. $112.4 million in total assets was reported for the 1HY20 period.
Cash and cash equivalents totalled $85.2 million for 1HY21 compared to $80 million for 1HY20.
The company received a $3.4 million R&D tax incentive during 1Hy21.
Chief medical officer shares insight
Paradigm chief medical officer Dr Donna Skerrett commented on Paradigm’s progress during the period, saying:
During CY 2020, Paradigm conducted a number of non-clinical and clinical studies to provide updated information regarding drug characteristics, pharmacokinetics, and non-clinical toxicity as requested by the FDA in the company’s first meeting with the agency in February 2020.
Paradigm has worked diligently to ensure it has all the necessary supporting non-clinical and clinical data and clinical development plan to support its IND submission in Q1 CY 2021.
Paradigm share price snapshot
Over the past year, the Paradigm share price has dropped about 26%.
The company’s market capitalisation is $578.2 million. Paradigm currently has 225.9 million shares outstanding.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
Motley Fool contributor Gretchen Kennedy has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.